Recruiting Lupus Nephritis Studies in Philadelphia
About Lupus Nephritis Clinical Trials in Philadelphia
Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, occurring in up to 60% of SLE patients. It can lead to kidney failure if untreated. Treatment includes immunosuppressive medications such as mycophenolate, cyclophosphamide, and newer agents like voclosporin.
There are currently 2 lupus nephritis clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 220 participants. Research is being sponsored by Temple University, Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Nephritis Clinical Trials in Philadelphia — FAQ
Are there lupus nephritis clinical trials in Philadelphia?
Yes, there are 2 lupus nephritis clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What lupus nephritis treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for lupus nephritis.
Data updated July 13, 2026 from ClinicalTrials.gov